» Articles » PMID: 11297896

Modeling and Comparison of Dissolution Profiles

Overview
Journal Eur J Pharm Sci
Specialties Chemistry
Pharmacology
Date 2001 Apr 12
PMID 11297896
Citations 915
Authors
Affiliations
Soon will be listed here.
Abstract

Over recent years, drug release/dissolution from solid pharmaceutical dosage forms has been the subject of intense and profitable scientific developments. Whenever a new solid dosage form is developed or produced, it is necessary to ensure that drug dissolution occurs in an appropriate manner. The pharmaceutical industry and the registration authorities do focus, nowadays, on drug dissolution studies. The quantitative analysis of the values obtained in dissolution/release tests is easier when mathematical formulas that express the dissolution results as a function of some of the dosage forms characteristics are used. In some cases, these mathematic models are derived from the theoretical analysis of the occurring process. In most of the cases the theoretical concept does not exist and some empirical equations have proved to be more appropriate. Drug dissolution from solid dosage forms has been described by kinetic models in which the dissolved amount of drug (Q) is a function of the test time, t or Q=f(t). Some analytical definitions of the Q(t) function are commonly used, such as zero order, first order, Hixson-Crowell, Weibull, Higuchi, Baker-Lonsdale, Korsmeyer-Peppas and Hopfenberg models. Other release parameters, such as dissolution time (tx%), assay time (tx min), dissolution efficacy (ED), difference factor (f1), similarity factor (f2) and Rescigno index (xi1 and xi2) can be used to characterize drug dissolution/release profiles.

Citing Articles

Sustainable nanophytosome-based therapies against multidrug-resistant Escherichia coli in urinary tract infections: an in Vitro and in vivo study.

Wen M, Abdelwahab I, Abozahra R, Abdelhamid S, Baraka K, Ahmed H J Nanobiotechnology. 2025; 23(1):174.

PMID: 40050888 PMC: 11883929. DOI: 10.1186/s12951-024-03006-1.


RSM and AI based machine learning for quality by design development of rivaroxaban push-pull osmotic tablets and its PBPK modeling.

Saleem M, Shoaib M, Yousuf R, Siddiqui F Sci Rep. 2025; 15(1):7922.

PMID: 40050302 PMC: 11885842. DOI: 10.1038/s41598-025-91601-z.


Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain Delivery.

Stankovic T, Ilic T, Divovic Matovic B, Petkovic M, Dobricic V, Jancic I Pharmaceutics. 2025; 17(2).

PMID: 40006599 PMC: 11858841. DOI: 10.3390/pharmaceutics17020232.


Thermodynamic and Structural Characterization of a Mechanochemically Synthesized Pyrazinamide-Acetylsalicylic-Acid Eutectic Mixture.

Queiroz L, Lage M, Dos Santos C, Sarraguca M, Ribeiro P Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006026 PMC: 11859338. DOI: 10.3390/ph18020211.


Gossypin-Loaded Ethosome Gel for Cutaneous Administration: A Preliminary Study on Melanoma Cells.

Bondi A, Pula W, Benedusi M, Trinchera G, Baldisserotto A, Manfredini S Antioxidants (Basel). 2025; 14(2).

PMID: 40002373 PMC: 11852004. DOI: 10.3390/antiox14020186.